SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Eifel PJ, Berek JS, Thigpen JT. Cancer of the cervix, vagina and vulva. In: DevitaVT, HellmanS, RosenbergSA, editors. Cancer: principles and practice of oncology, 6th ed. Philadelphia: Lippincott, 2001: 15261556.
  • 2
    Lyng H, Sundfør K, Tropé C, Rofstad EK. Disease control of uterine cervical cancer: relationship to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res. 2000; 6: 11041112.
  • 3
    Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF. Cyclooxygenase-2 expression in human glioma: prognostic significance and molecular correlations. Cancer Res. 2001; 61: 43754381.
  • 4
    Kang HJ, Gong G, Jang SJ, Jung PJ, Park CK. Expression of cyclooxygenase-2 in human breast carcinoma: relevance to tumor angiogenesis and expression of estrogen receptor [in Korean]. Cancer Res Treat. 2001; 33: 286295.
  • 5
    Khuri FR, Wu H, Lee J, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in Stage I non-small cell lung cancer. Clin Cancer Res. 2001; 7: 861867.
  • 6
    Shamma A, Yamamoto H, Doki Y, et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res. 2000; 6: 12291238.
  • 7
    Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric cancer. Clin Cancer Res. 2000; 6: 519525.
  • 8
    Sheehan KM, Sheahan K, O'Donoghue DP, et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA. 1999; 282: 12541257.
  • 9
    Tomozawa S, Tsuno NH, Sunami E, et al. Cyclooxygenase-2 overexpression correlates with tumor recurrence, specially haematogenous metastasis, of colorectal cancer. Br J Cancer. 2000; 83: 324328.
  • 10
    Masunuga R, Kohno H, Dhar K, et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human cororectal carcinoma patients. Clin Cancer Res. 2000; 6: 40644068.
  • 11
    Ryu HS, Chang KH, Yang HW, Kim MS, Kwon HC, Oh KS. High cyclooxygenase-2 expression in Stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol Oncol. 2000; 76: 320325.
  • 12
    Gaffney DK, Holden J, Davis M, Zempolich K, Murphy KJ, Dodson M. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2001; 49: 12131217.
  • 13
    Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin Invest. 2001; 107: 14911495.
  • 14
    Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000; 69: 145182.
  • 15
    Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999; 18: 79087916.
  • 16
    Wolff H, Saukkonen, K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 1998; 58: 49975001.
  • 17
    Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 2000; 89: 26372645.
  • 18
    Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 1999; 59: 43564362.
  • 19
    Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994; 107: 11831188.
  • 20
    Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulated carcinoma growth. J Clin Invest. 2000; 105: 15891594.
  • 21
    Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995; 83: 493501.
  • 22
    Elder DJ, Halton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res. 1997; 3: 16791683.
  • 23
    Tsujii M, Kawano S, DuBois RN. Cyclooxtgenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 1997; 94: 33363340.
  • 24
    Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 2000; 60: 13061311.
  • 25
    Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999; 340: 11371143.
  • 26
    Rose PG, Bundy BN, Watkind EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999; 340: 11441153.
  • 27
    Park TK, Kim SN, Kim SW, Kim GE, Suh CO. Concurrent chemotherapy and radiotherapy in invasive cervical carcinoma patients with high risk factors. J Korean Med Sci. 2000; 15: 436441.
  • 28
    Spencer AG, Woods JW, Arakawa T, Singer II, Smith WL. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J Biol Chem. 1998; 273: 98869893.
  • 29
    Dannenberg AJ, Altoki NK, Boyle JO, et al. Cyclooxygenase-2: a pharmacological target for the prevention of cancer. Lancet Oncol. 2001: 2; 544551.
  • 30
    Doré M, Côté LC, Mitchell A, Sirois J. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas. J Histochem Cytochem. 1998; 46: 7784.
  • 31
    Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 1998; 90: 455460.
  • 32
    Zhang Y, DeWitt DL, McNeely TB, Wahl SM, Wahl LM. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest. 1997; 99: 894900.
  • 33
    Gorski DH, Beckett MA, Jaskowiak NT, et al. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 1999; 59: 33743378.
  • 34
    Hida T, Leyton J, Makheja AN, et al. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs. Anticancer Res. 1998; 18: 775782.
  • 35
    Duffy CP, Elliott CJ, O'Connor RA, et al. Enhancement of chemotherapeutic drug toxicity to human tumor cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs). Eur J Cancer. 1998; 34: 12501259.
  • 36
    Milas L, Kishi K, Hunter N, Mason K, Masferrer JL, Tofilon PJ. Enhancement of tumor response to γ-radiation by an inhibitor of cyclooxygenase-2 enzyme. J Natl Cancer Inst. 1999; 91: 15011504.
  • 37
    Kishi K, Petersen S, Petersen C, et al. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res. 2000; 60: 13261331.